Aytu Biopharma (AYTU) Work In Process (2021 - 2025)
Historic Work In Process for Aytu Biopharma (AYTU) over the last 5 years, with Q4 2025 value amounting to $1.8 million.
- Aytu Biopharma's Work In Process fell 4147.6% to $1.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.8 million, marking a year-over-year decrease of 4147.6%. This contributed to the annual value of $1.4 million for FY2025, which is 7587.77% down from last year.
- Latest data reveals that Aytu Biopharma reported Work In Process of $1.8 million as of Q4 2025, which was down 4147.6% from $862000.0 recorded in Q3 2025.
- Aytu Biopharma's 5-year Work In Process high stood at $5.7 million for Q2 2024, and its period low was $862000.0 during Q3 2025.
- Its 5-year average for Work In Process is $2.8 million, with a median of $2.8 million in 2022.
- In the last 5 years, Aytu Biopharma's Work In Process surged by 9367.39% in 2024 and then plummeted by 7587.77% in 2025.
- Over the past 5 years, Aytu Biopharma's Work In Process (Quarter) stood at $2.2 million in 2021, then grew by 28.99% to $2.8 million in 2022, then decreased by 4.6% to $2.7 million in 2023, then rose by 16.04% to $3.1 million in 2024, then tumbled by 41.48% to $1.8 million in 2025.
- Its Work In Process was $1.8 million in Q4 2025, compared to $862000.0 in Q3 2025 and $1.4 million in Q2 2025.